Companies / ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc.
Financials · FY2025
Ownership
99.3M shares outstanding · as of May 13, 2026
Ownership
| 10%+ / strategic | 5.05% | 5,013,000 |
| Institutions | 90.14% | 89,515,071 |
| Public float | 4.81% | 4,775,191 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 15
View all →| Insider | % of shares | Shares |
|---|---|---|
Fitzpatrick Alexander AFormerChief Legal Officer | 0.09% | 90,910 |
Chakma JustinChief Business Officer | — | — |
Dorsey BrianFormerChief Operating Officer | — | — |
Karas EricFormerChief Commercial Officer | — | — |
Kolchinsky PeterDirector · 10% owner | — | — |
Lowenthal Richard ECEOPRESIDENT AND CEO · Director · 10% owner | — | — |
RA Capital Healthcare Fund LPFormerDirector · 10% owner | — | — |
RA Capital Management, L.P.FormerDirector · 10% owner | — | — |
RA Capital Nexus Fund II, L.P.FormerDirector | — | — |
Saunders Brent LFormerDirector | — | — |
Institutional holders 200
View all →| Holder | Value | % of shares |
|---|---|---|
| $87.21M | 10.94% | |
| $72.23M | 6.24% | |
| $66.56M | 8.35% | |
| $60.26M | 7.56% | |
| $48.04M | 6.02% | |
| $46.75M | 4.04% | |
| $42.54M | 5.35% | |
| $41.43M | 3.58% | |
| $40.88M | 3.53% | |
| $29.88M | 3.76% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Millennium Management LLC 13F manager | Add | — | $22.60M | +2.8M +88.83% | 5,982,919 6.02% of shares | medium |
| Q1 2026 as of | Southpoint Capital Advisors LP 13F manager | Exit | — | $-17.48M | -1.5M -100.00% | — | medium |
| Q2 2025 as of | Barclays PLC 13F manager | Add | — | $8.55M | +490K +371.27% | 622,235 0.63% of shares | medium |
| Q1 2026 as of | Pavaki Capital Management LLC 13F manager | Trim | — | $-4.78M | -596K -50.84% | 576,200 0.58% of shares | low |
| Q2 2026 as of | State Street Corporation 13F manager | Add | — | $4.06M | +507K +15.73% | 3,730,623 3.76% of shares | low |
| Q3 2025 as of | Barclays PLC 13F manager | Trim | — | $-3.96M | -394K -63.27% | 228,569 0.23% of shares | low |
| Q1 2026 as of | Third Point LLC 13F manager | Add | — | $3.56M | +444K +79.78% | 1,000,000 1.01% of shares | low |
| Q1 2026 as of | First Trust Advisors LP 13F manager | New | — | $3.39M | +422K | 422,038 0.42% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Millennium Management LLC | Passive13G/A | — |
| Millennium Management LLC | Passive13G | — |
| BlackRock, Inc. | Passive13G | — |
| Rubric Capital Management LP | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| SPRY | — | 82835W108 |